Abstract
Rac proteins constitute a subgroup of the Rho family of small GTPases and include Rac1, which is expressed ubiquitously, and Rac2, a highly homologous protein only expressed in myelo-monocytic and lymphoid cell lineages. In fibroblasts, Rac1 plays a crucial role in control of actin cytoskeleton organisation, cell growth and Ras-induced transformation. In phagocytes, Rac1 and Rac2 regulate a specific enzymatic complex, NADPH oxidase. These multiple functions have been ascribed to Rac proteins only on the basis of cell culture and in vitro biochemical studies. To examine the role of Rac2 in vivo in a T cell lineage, we have expressed either wild-type or constitutively-activated forms of human Rac2 (Rac2V12 and Rac2L61) in transgenic mice under control of the thymus specific lck proximal promoter. We report here a striking atrophy of the thymus in mice expressing even low levels of either of the activated mutants of Rac2, while expression of Rac2wt has no effect. This phenotype is correlated with a marked decrease in the number of double positive (CD4+CD8+) and single positive (CD4+CD8− and CD8+CD4−) thymocytes. Cellular and molecular analyses demonstrate that this defect is due to an increase in apoptosis among thymocytes. As Rac2 is normally expressed in thymocytes and activated T cells, we propose that Rac2 dependent pathways could play an important role in control of growth and death of T cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lorès, P., Morin, L., Luna, R. et al. Enhanced apoptosis in the thymus of transgenic mice expressing constitutively activated forms of human Rac2GTPase. Oncogene 15, 601–605 (1997). https://doi.org/10.1038/sj.onc.1201378
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1201378
Keywords
This article is cited by
-
Combined Immunodeficiency Caused by a Novel De Novo Gain-of-Function RAC2 Mutation
Journal of Clinical Immunology (2022)
-
RCC2 over-expression in tumor cells alters apoptosis and drug sensitivity by regulating Rac1 activation
BMC Cancer (2018)
-
Rho family GTPases and their regulators in lymphocytes
Nature Reviews Immunology (2009)
-
Increased Rac2 mRNA expression in peripheral blood during human corneal graft rejection
Eye (2009)
-
RhoG regulates gene expression and the actin cytoskeleton in lymphocytes
Oncogene (2003)